Literature DB >> 15694400

Parathyroid hormone and parathyroid hormone-related peptide, and their receptors.

Robert C Gensure1, Thomas J Gardella, Harald Jüppner.   

Abstract

Parathyroid hormone (PTH) has a central role in the regulation of serum calcium and phosphate, while parathyroid hormone-related peptide (PTHrP) has important developmental roles. Both peptides signal through the same receptor, the PTH/PTHrP receptor (a class B G-protein-coupled receptor). The different biological effects of these ligands result from their modes of regulation and secretion, endocrine vs. paracrine/autocrine. The importance of PTH and PTHrP is evident by the variety of clinical syndromes caused by deficiency or excess production of either peptide, and the demonstration that intermittent injection of PTH increases bone mass, and thus provides a means to treat osteoporosis. This, in turn, has triggered increased interest in understanding the mechanisms of PTH/PTHrP receptor action and the search for smaller peptide or non-peptide agonists that have efficacy at this receptor when administered non-parenterally.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694400     DOI: 10.1016/j.bbrc.2004.11.069

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  88 in total

1.  Treatment for chemotherapy-induced alopecia in mice using parathyroid hormone agonists and antagonists linked to a collagen binding domain.

Authors:  Ranjitha Katikaneni; Tulasi Ponnapakkam; Hirofumi Suda; Shigeru Miyata; Joshua Sakon; Osamu Matsushita; Robert C Gensure
Journal:  Int J Cancer       Date:  2012-01-24       Impact factor: 7.396

2.  Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism.

Authors:  Marián Castro; Viacheslav O Nikolaev; Dieter Palm; Martin J Lohse; Jean-Pierre Vilardaga
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-18       Impact factor: 11.205

3.  Conformational changes in the parathyroid hormone receptor associated with activation by agonist.

Authors:  Beena E Thomas; Iwona Woznica; Dale F Mierke; Angela Wittelsberger; Michael Rosenblatt
Journal:  Mol Endocrinol       Date:  2008-02-07

4.  Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.

Authors:  Thomas Dean; Jean-Pierre Vilardaga; John T Potts; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2007-09-13

5.  Residue 17 of sauvagine cross-links to the first transmembrane domain of corticotropin-releasing factor receptor 1 (CRFR1).

Authors:  Iman Assil-Kishawi; Tareq A Samra; Dale F Mierke; Abdul B Abou-Samra
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

6.  PTHrP is a novel mediator for TGF-β-induced apoptosis.

Authors:  Yanna Cao; Weili Zhang; Xuxia Gao; Guohua Zhang; Miriam Falzon; Courtney M Townsend; Mark R Hellmich; Tien C Ko
Journal:  Regul Pept       Date:  2013-03-13

7.  Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone.

Authors:  Richard S Kao; Marcia J Abbott; Alyssa Louie; Dylan O'Carroll; Weidar Lu; Robert Nissenson
Journal:  Bone       Date:  2013-04-10       Impact factor: 4.398

8.  PTH-induced internalization of apical membrane NaPi2a: role of actin and myosin VI.

Authors:  Judith Blaine; Kayo Okamura; Hector Giral; Sophia Breusegem; Yupanqui Caldas; Andrew Millard; Nicholas Barry; Moshe Levi
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-23       Impact factor: 4.249

9.  Agonist-regulated cleavage of the extracellular domain of parathyroid hormone receptor type 1.

Authors:  Christoph Klenk; Stefan Schulz; Davide Calebiro; Martin J Lohse
Journal:  J Biol Chem       Date:  2010-01-15       Impact factor: 5.157

10.  Regulation of bone formation and remodeling by G-protein-coupled receptor 48.

Authors:  Jian Luo; Wei Zhou; Xin Zhou; Dali Li; Jinsheng Weng; Zhengfang Yi; Sung Gook Cho; Chenghai Li; Tingfang Yi; Xiushan Wu; Xiao-Ying Li; Benoit de Crombrugghe; Magnus Höök; Mingyao Liu
Journal:  Development       Date:  2009-07-15       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.